Following is a summary of a Discussion Paper that is part of a
series of scientific papers funded by AHCPR to support the
performance measurement efforts of the Foundation for
Accountability (FACCT). The authors of these papers reviewed the
science base and provided recommendations on measures. FACCT had
identified the topics covered in this
series—population-level measurement areas such as
satisfaction and a number of clinical conditions—as first
priorities.
This Discussion Paper first reviews activities underway in
developing diabetes quality-of-care measures. Next, specific
measures are recommended and ranked as either optimal or good.
Optimal measures are usually more expensive, and many are outcome
measures. Good measures are usually measures that are currently
accepted and more feasible for immediate use.
Recommended measures are grouped along several dimensions:
- Glycemic control.
- Eye disease.
- Extremity disease.
- Lipids.
- Kidney disease.
- Hypertension.
- Heart disease.
- Obesity.
- Health-related quality of life.
The authors conclude that it is possible to identify valid and
reliable measures for diabetes that can be used to measure
quality of life, clinical outcomes, and essential processes. Some
optimal measures may require effort and refinement but deserve
serious appraisal.
This Discussion Paper was written by Sheldon Greenfield, M.D.,
Sherrie Kaplan, Ph.D., M.P.H., and Sarah Purdy, M.B., B.S.,
M.P.H., of the Primary Care Outcomes Research Institute at New
England Medical Center.
Current as of August 1996
Internet Citation:
Measuring Health Care Quality: Diabetes. August 1996. Agency for Healthcare Research and Quality, Rockville, MD. http://www.ahrq.gov/qual/diabetes.htm